2021 annual financial data
Marker Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -2,196.95%.
Operating income was -39,477,995 USD and net income was -41,878,871 USD.
Operating cash flow was -27,279,765 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,241,710 USD
- Operating income
- -39,477,995 USD
- Net income
- -41,878,871 USD
- Operating cash flow
- -27,279,765 USD